Innovative Diabetes Care Solutions
Ascensia Diabetes Care (ascensia.com) earns a Brand Analyzer score of 77 out of 100, placing it in the Brand-Ready tier among Healthcare brands. Among 3529 Healthcare brands analyzed, Ascensia Diabetes Care ranks in the 70th percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 85/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 100/100, Trust Foundation 90/100, AI Discoverability 50/100, Brand Authority 33/100.
Ascensia Diabetes Care is a global healthcare company headquartered in Basel, Switzerland, founded in 2016. It is entirely dedicated to diabetes care, offering blood glucose monitoring systems under the CONTOUR brand. The company combines advanced technology with user-friendly functionality, supported by specialist expertise in diabetes management. Its target audience includes people living with diabetes and healthcare providers who support diabetes management.
| Brand Name | Ascensia Diabetes Care |
|---|---|
| Domain | ascensia.com |
| Industry | Healthcare |
| Founded | 2016 |
| Headquarters | Peter Merian Building |
| Main Competitors | Roche Diabetes Care (93/100), Abbott (FreeStyle) (91/100), Dexcom (84/100), LifeScan (OneTouch), Medtronic Diabetes (83/100), Trividia Health |
Moz Domain Authority 42/100 vs category average 35 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #559,716 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Ascensia Diabetes Care is a global company entirely dedicated to improving the health and lives of people with diabetes." (Meta description: 19 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: ASP.NET, Cloudflare.
Social footprint: verified profiles on Instagram, LinkedIn, X (Twitter), GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Ascensia Diabetes Care scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Ascensia Diabetes Care has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #559,716 (Tranco) and a Moz Domain Authority of 42/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Ascensia Diabetes Care from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Ascensia Diabetes Care?", Claude could identify the brand as of August 2026. Ascensia Diabetes Care is a global diabetes management company that makes blood glucose monitoring systems, including the Contour brand of glucometers and test strips. It was spun off from Bayer's diabetes care business in 2016 and is now owned by PHC Holdings (formerly Panasonic Best known for Contour blood glucose meters and test strips.
When asked "Best brands similar to Ascensia Diabetes Care?", Claude would recommend Ascensia Diabetes Care as of August 2026. It's a well established name in blood glucose monitoring alongside brands like Abbott's FreeStyle and Roche's Accu-Chek, so it would naturally come up in that comparison.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Ascensia Diabetes Care's main competitors include Roche Diabetes Care (93/100), Abbott (FreeStyle) (91/100), Dexcom (84/100), LifeScan (OneTouch), Medtronic Diabetes (83/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Ascensia Diabetes Care and Roche Diabetes Care are competitors in Healthcare. Brand Analyzer scores Ascensia Diabetes Care at 77/100 and Roche Diabetes Care at 93/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Ascensia Diabetes Care include Roche Diabetes Care (93/100), Abbott (FreeStyle) (91/100), Dexcom (84/100), LifeScan (OneTouch), Medtronic Diabetes (83/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Ascensia Diabetes Care has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 26, trust 29, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Ascensia Diabetes Care official site
Ascensia Diabetes Care was founded in 2016. Ascensia Diabetes Care operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Ascensia Diabetes Care is headquartered in Peter Merian Building. Ascensia Diabetes Care operates in the Healthcare category.
Sources: Wikidata
Ascensia Diabetes Care scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Ascensia Diabetes Care official site
Ascensia Diabetes Care offers blood glucose monitoring systems under the CONTOUR brand, which combine advanced technology with user-friendly functionality to support diabetes management for patients and healthcare providers.
Sources: Ascensia Diabetes Care official site
Ascensia Diabetes Care is a global healthcare company headquartered in Basel, Switzerland, founded in 2016. It is entirely dedicated to improving the health and lives of people with diabetes through innovative care solutions.
Sources: Ascensia Diabetes Care official site
Ascensia Diabetes Care can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Ascensia Diabetes Care official site
Ascensia Diabetes Care's products are used by people living with diabetes who need reliable blood glucose monitoring, as well as healthcare providers who support diabetes management.
Sources: Ascensia Diabetes Care official site
Ascensia Diabetes Care is known for its CONTOUR line of blood glucose monitoring systems, which combine advanced technology with user-friendly design, and for being a company entirely focused on diabetes care rather than general healthcare.
Sources: Ascensia Diabetes Care official site
Ranked closest to Ascensia Diabetes Care: Alexandria Real Estate Equities (Alexandria®) (77/100), Archy (77/100), Ashland (77/100), Avanti Research (77/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).